CanSino Biologics Inc.

OTCPK:CASB.F Stock Report

Market Cap: US$1.4b

CanSino Biologics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:CASB.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
26 Sep 24BuyUS$56,057Xuefeng YuIndividual20,000US$2.80
09 Sep 24BuyUS$47,116Xuefeng YuIndividual20,000US$2.36
09 Sep 24BuyUS$70,490Shou-Bai ChaoIndividual30,000US$2.35
25 Jul 24BuyUS$2,329Jing WangIndividual1,000US$2.33
24 Jul 24BuyUS$23,781Xuefeng YuIndividual10,000US$2.38
24 Jul 24BuyUS$16,535Jing WangIndividual7,000US$2.36
15 Jul 24BuyUS$7,287Jing WangIndividual3,000US$2.43
12 Jul 24BuyUS$37,430Shou-Bai ChaoIndividual15,000US$2.50
10 Jul 24BuyUS$12,000Shou-Bai ChaoIndividual5,000US$2.40
09 Jul 24BuyUS$48,281Xuefeng YuIndividual20,000US$2.41
09 Jul 24BuyUS$18,632Jing WangIndividual7,800US$2.39

Insider Trading Volume

Insider Buying: CASB.F insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CASB.F?
Owner TypeNumber of SharesOwnership Percentage
Employee Share Scheme277,6500.112%
Private Companies15,497,7636.27%
Institutions28,415,21311.5%
General Public99,015,99240.1%
Individual Insiders103,837,18342%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 58.82% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12%
Xuefeng Yu
29,534,383US$172.1m0.24%no data
11.4%
Dongxu Qiu
28,217,917US$164.5m0.07%no data
11%
Huihua Mao
27,121,741US$158.1m0.01%no data
7.27%
Tao Zhu
17,962,400US$104.7m0.49%no data
3.04%
Qm29 Limited
7,516,538US$43.8m0%no data
1.95%
Goldman Sachs Group, Investment Banking and Securities Investments
4,809,877US$28.0m0%0.01%
1.53%
The Vanguard Group, Inc.
3,774,623US$22.0m2.04%no data
1.41%
Tianjin Qianyi Enterprise Management Partnership Enterprise (Limited Partnership)
3,474,600US$20.3m0%no data
1.34%
Tianjin Qianrui Enterprise Management Partnership Enterprise (Limited Partnership)
3,299,475US$19.2m0%no data
1.17%
SDIC Innovation Investment Management Co., Ltd.
2,883,810US$16.8m0%1.49%
1.12%
Citigroup Inc.,Banking and Securities Investments
2,778,861US$16.2m0%0.01%
0.7%
JPMorgan Chase & Co, Brokerage and Securities Investments
1,732,962US$10.1m0%no data
0.62%
GF Fund Management Co., Ltd.
1,534,311US$8.9m0%0.01%
0.6%
Bosera Asset Management Co., Ltd.
1,490,170US$8.7m0%0.02%
0.57%
BlackRock, Inc.
1,416,801US$8.3m0.64%no data
0.56%
Barclays PLC Private Banking & Investment Banking Investment
1,395,072US$8.1m0%0.01%
0.52%
China Merchants Fund Management Company Ltd.
1,291,998US$7.5m0%0.05%
0.49%
Shanghai Qianxizhi Enterprise Management Partnership (Limited Partnership)
1,207,150US$7.0m0%no data
0.36%
Capital Research and Management Company
900,919US$5.3m0%no data
0.34%
Yinhua Fund Management Co., Ltd.
848,680US$4.9m0%0.05%
0.27%
Zhongqi Shao
675,000US$3.9m0%no data
0.19%
Enterprise Annuity Plan of Industrial and Commercial Bank of China Co., Ltd
465,025US$2.7m0%2.66%
0.16%
Dimensional Fund Advisors LP
401,600US$2.3m0%no data
0.12%
First Trust Advisors LP
302,800US$1.8m0%no data
0.11%
Cansino Biologics Inc., ESOP
277,650US$1.6m0%no data